Somerset Indus Capital Partners
VC Fund
Port Louis, Mauritius
Somerset Indus Capital Partners is a VC fund in Port Louis focused on Health Care and Medical. Somerset Indus Capital Partners seeks to make private equity and equity-related investments primarily in growth-oriented healthcare companies in India. Somerset is led by Avinash Kenkare on the offshore fund side, a private equity professional with eighteen years of successful investing experience in over fifteen transactions, and duly assisted byMayur Sirdesai on domestic fund side, a healthcare professional with over twenty years of experience in the Indian Pharma/ Healthcare Industry with both private equity, operational and consulting services related experience.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Somerset Indus Capital Partners invests in
Stages Somerset Indus Capital Partners invests in
Countries Somerset Indus Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Private Equity
- $10M–$17M
Investment Focus
Industry
- Health Care 10 (67%)
- Medical 7 (47%)
- Manufacturing 5 (33%)
- Hospital 4 (27%)
- Medical Device 4 (27%)
Stage
- Private Equity 4 (27%)
- Series A 3 (20%)
- Funding Round 3 (20%)
- Seed 2 (13%)
- Venture - Series Unknown 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Avinash Kenkare
Partner
|
Partner | Total investments: 0 | Find email | |
Mayur Sirdesai
Partner and Founder
|
Partner and Founder | Total investments: 2 | Find email | |
Ramesh Kannan
partner
|
partner | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cyrix Healthcare
|
Cyrix Healthcare is a healthcare solutions provider that delivers medical equipment. | $16.5M / Private Equity / Dec 09, 2024 | |
Genworks
|
Genworks provides healthcare solutions and medical devices to offer telemedicine services across various healthcare sectors. It focuses on offerings that include equipment for cardiology, ENT, femtech, in vitro diagnostics (IVD), neonatal care, radiology, respiratory diagnostics, and surgical solutions. | $4.9M / Venture - Series Unknown / Aug 08, 2024 | |
Printmann Group
|
Printmann Group is a manufacturing company that provides packaging solutions for the pharmaceutical, food, and FMCG industries. | Private Equity / Feb 13, 2024 | |
Emil Pharmaceutical
|
Emil Pharmaceutical is responsible for creating, producing, and selling medications of a quality that is recognised worldwide. | $14.6M / Private Equity / Apr 25, 2023 | |
|
Genworks
|
Genworks provides healthcare solutions and medical devices to offer telemedicine services across various healthcare sectors. It focuses on offerings that include equipment for cardiology, ENT, femtech, in vitro diagnostics (IVD), neonatal care, radiology, respiratory diagnostics, and surgical solutions. | $17.8M / Venture - Series Unknown / May 04, 2022 | |
Globela Pharma
|
Globela Pharma is a pharmaceutical formulation manufacturing company. | $10M / Private Equity / Oct 06, 2021 | |
Krsnaa Diagnostics
|
Krsnaa Diagnostics provides clinical excellence through collaborative teleradiology services, allowing patients to receive robust evidence-based treatment from anywhere in the country. Well-qualified radiologists and pathologists from around the world deliver accurate reports using the most advanced technology, including an advanced cloud-basedPACS workflow capable of rapid deployment and easy integration into flexible operational needs.Krsnaa Diagnostics is India's largest provider of diagnostic services in both Radiology and Pathology. It aims to be easily accessible and affordable to anyone who seeks best quality diagnosis. | $1.8M / Mar 01, 2017 | |
Prognosys Medical Systems
|
Prognosys Medical Systems manufactures X-ray equipment. | $643K / Feb 01, 2017 | |
Hexagon Nutrition
|
Manufacturers & Marketers of Pentasure Brands, Clinical Nutrition Supplements, Enteral Nutrition Supplements, Pediatric Nutrition, Geriatric Nutrition etc. Manufacturers and Marketers of Vitamin Premixes & Mineral Premixes for fortification of Health Foods, Fortified Foods, flour, Oil. | Series A / Dec 08, 2016 | |
Browndove Healthcare
|
Browndove Healthcare provides solutions and addressing customer needs in the renal care space. | Seed / Mar 08, 2016 | |
| See all 15 investments → | |||
Co-Investors
Morgan Stanley
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Somerset Indus Capital Partners invest in?
Somerset Indus Capital Partners invests primarily in Health Care, Medical and Manufacturing startups, most often at Private Equity and Series A stage. Most of the 15 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Somerset Indus Capital Partners's check size?
Somerset Indus Capital Partners typically joins rounds of $10M–$17M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Somerset Indus Capital Partners participates in.
How do I contact Somerset Indus Capital Partners?
Public channels for Somerset Indus Capital Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Somerset Indus Capital Partners?
The team at Somerset Indus Capital Partners includes Avinash Kenkare (Partner), Mayur Sirdesai (Partner and Founder) and Ramesh Kannan (partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
